Benjamin K Tsang
Overview
Explore the profile of Benjamin K Tsang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
2897
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Siu M, Jiang Y, Wang J, Leung T, Han C, Tsang B, et al.
Cancers (Basel)
. 2024 Nov;
16(21).
PMID: 39518159
In the original publication [...].
2.
Duval C, Wyse B, Tsang B, Librach C
J Ovarian Res
. 2024 Aug;
17(1):160.
PMID: 39103867
Extracellular vesicles (EVs), particles enriched in bioactive molecules like proteins, nucleic acids, and lipids, are crucial mediators of intercellular communication and play key roles in various physiological and pathological processes....
3.
Onuma T, Asare-Werehene M, Fujita Y, Yoshida Y, Tsang B
Cells
. 2024 Jun;
13(11.
PMID: 38891037
Plasma gelsolin (pGSN) overexpression in ovarian cancer (OVCA) disarms immune function, contributing to chemoresistance. The aim of this study was to investigate the immunoregulatory effects of pGSN expression on natural...
4.
Xiao C, Carbonel A, Lima P, Hendry A, Tsang B
Br J Nutr
. 2024 Jun;
:1-9.
PMID: 38826091
Polycystic ovary syndrome is associated with increased risks for certain metabolic disorders such as insulin resistance, non-alcoholic fatty liver disease and suppressed ovarian follicular development. This study aimed to examine...
5.
Manzoor H, Asare-Werehene M, Pereira S, Satyamoorthy K, Tsang B
J Ovarian Res
. 2024 Jan;
17(1):15.
PMID: 38216951
Background: Ovarian cancer (OVCA) is the most lethal gynecologic cancer and chemoresistance remains a major hurdle to successful therapy and survival of OVCA patients. Plasma gelsolin (pGSN) is highly expressed...
6.
Wyse B, Salehi R, Russell S, Sangaralingam M, Jahangiri S, Tsang B, et al.
Front Endocrinol (Lausanne)
. 2023 Jul;
14:1205385.
PMID: 37404312
Introduction: The ovarian follicle consists of the oocyte, somatic cells, and follicular fluid (FF). Proper signalling between these compartments is required for optimal folliculogenesis. The association between polycystic ovarian syndrome...
7.
Asare-Werehene M, Hunter R, Gerber E, Reunov A, Brine I, Chang C, et al.
Cancers (Basel)
. 2023 May;
15(9).
PMID: 37174032
Background: Ovarian cancer (OVCA) is the most fatal gynecological cancer with late diagnosis and plasma gelsolin (pGSN)-mediated chemoresistance representing the main obstacles to treatment success. Since there is no reliable...
8.
Salehi R, Wyse B, Asare-Werehene M, Esfandiarinezhad F, Abedini A, Pan B, et al.
J Ovarian Res
. 2023 Apr;
16(1):74.
PMID: 37046285
Polycystic ovarian syndrome (PCOS) is a complex multi-factorial syndrome associated with androgen excess and anovulatory infertility. In the current study, we investigated the role of dihydrotestosterone-induced exosomal miR-379-5p release in...
9.
Salehi R, Asare-Werehene M, Wyse B, Abedini A, Pan B, Gutsol A, et al.
Front Immunol
. 2023 Apr;
14:1104550.
PMID: 37033997
Polycystic ovarian syndrome (PCOS) is associated with hyperandrogenemia and ovarian antral follicle growth arrest. We have previously demonstrated that androgen-induced exosomal release of miR-379-5p (miR379) from preantral follicle granulosa cells...
10.
Gerber E, Asare-Werehene M, Reunov A, Burger D, Le T, Carmona E, et al.
J Ovarian Res
. 2023 Jan;
16(1):14.
PMID: 36642715
Background: Resistance to chemotherapy continues to be a challenge when treating epithelial ovarian cancer (EOC), contributing to low patient survival rates. While CA125, the conventional EOC biomarker, has been useful...